Inovio Pharmaceuticals, Inc. (INO)

Inovio Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	14.31	46.33	71.14	250.73	22.2
Short-Term Investments	130.98	206.67	330.17	160.91	67.34
Cash & Cash Equivalents	145.29	253	401.31	411.64	89.53
Cash Growth	-42.57%	-36.96%	-2.51%	359.76%	10.22%
Receivables	2.41	11.74	8.03	19.06	2.03
Other Current Assets	5.41	50.51	39.1	40.46	2.63
Total Current Assets	153.11	315.24	448.44	471.17	94.2
Property, Plant & Equipment	14.45	17.96	29.02	24.09	26.56
Long-Term Investments	2.78	2.01	3.91	4.89	6.32
Goodwill and Intangibles	0	12.64	13.14	13.66	14.21
Other Long-Term Assets	0.61	0.68	1.43	25.96	2.67
Total Long-Term Assets	17.84	33.29	47.5	68.6	49.75
Total Assets	170.95	348.53	495.94	539.77	143.95
Accounts Payable	20.92	80.91	48.19	21.85	18.97
Deferred Revenue	0	0	0.09	0.13	0.23
Current Debt	19.18	2.8	2.6	2.33	2.07
Other Current Liabilities	2.47	13.16	14.86	17.4	10.72
Total Current Liabilities	42.57	96.87	65.74	41.71	31.99
Long-Term Debt	11.03	29.27	30.42	36.72	97.43
Other Long-Term Liabilities	0	0.03	0.11	0.21	9.12
Total Long-Term Liabilities	11.03	29.3	30.53	36.93	106.56
Total Liabilities	53.6	126.17	96.27	78.63	138.55
Total Debt	30.21	32.07	33.02	39.05	99.51
Debt Growth	-5.82%	-2.87%	-15.43%	-60.76%	-
Retained Earnings	-1,622.97	-1,487.85	-1,209.86	-906.2	-739.79
Comprehensive Income	-0.66	-0.7	-0.28	-0.26	0.47
Shareholders' Equity	117.35	222.36	399.67	461.14	3.44
Net Cash / Debt	115.08	220.92	368.29	372.59	-9.97
Net Cash / Debt Growth	-47.91%	-40.01%	-1.15%	-	-
Net Cash Per Share	5.19	11.11	21.16	28.82	-1.21
Working Capital	110.54	218.37	382.7	429.46	62.21
Book Value Per Share	5.29	11.18	22.97	35.67	0.42

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).